S. 4152 — Introduced in Senate

II 117th CONGRESS 2d Session S. 4152 IN THE SENATE OF THE UNITED STATES May 5, 2022Mr. Kelly (for himself, Ms. Collins, and Ms. Sinema) introduced the following bill; which was read twice and referred to the Committee on Health, Education, Labor, and Pensions A BILL To amend the Federal Food, Drug, and Cosmetic Act to reauthorize the Critical Path Public-Private Partnerships. 1. Reauthorization of the Critical Path Public-Private Partnerships Section 566(f) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 360bbb–5(f)) is amended by striking $6,000,000 for each of fiscal years 2018 through 2022 and inserting $10,000,000 for each of fiscal years 2023 through 2027.